BDBM567661 US11420968, Example F21

SMILES C[C@]1(O)CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCC5(CC4)CC(N4CCC[C@H]4c4ccccc4C4CC4)C5)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1

InChI Key InChIKey=KFBCVCBDWRTMMY-UHFFFAOYSA-N

Data  7 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 567661   

TargetApoptosis regulator Bcl-2(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 567661BDBM567661(US11420968, Example F21)
Affinity DataIC50: 0.0220nMAssay Description:Compounds disclosed herein were tested for blocking of Bcl-2/Bcl-X protein with its ligand in an assay based on Time-Resolved Fluorescence Resonance ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 567661BDBM567661(US11420968, Example F21)
Affinity DataIC50: 0.0220nMAssay Description:Compounds disclosed herein were tested for blocking of Bcl-2/Bcl-xl protein with its ligand in an assay based on fluorescence polarization methodolog...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetApoptosis regulator Bcl-2 [G101V](Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 567661BDBM567661(US11420968, Example F21)
Affinity DataIC50: 0.930nMAssay Description:Selected compounds disclosed herein were tested for blocking of Bcl-2-G101 protein with its ligand in an assay based on time-resolved fluorescence re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 567661BDBM567661(US11420968, Example F21)
Affinity DataIC50: 1.60nMAssay Description:Compounds disclosed herein were tested for blocking of Bcl-2/Bcl-xl protein with its ligand in an assay based on fluorescence polarization methodolog...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 567661BDBM567661(US11420968, Example F21)
Affinity DataIC50: 24nMAssay Description:Compounds disclosed herein were tested for blocking of Bcl-2/Bcl-X protein with its ligand in an assay based on Time-Resolved Fluorescence Resonance ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetBcl-2-like protein 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 567661BDBM567661(US11420968, Example F21)
Affinity DataIC50: 24nMAssay Description:Compounds disclosed herein were tested for blocking of Bcl-2/Bcl-xl protein with its ligand in an assay based on fluorescence polarization methodolog...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetCytochrome P450 2C9(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 567661BDBM567661(US11420968, Example F21)
Affinity DataIC50: 3.00E+4nMAssay Description:The five isoform-selective probe substrate (in a cocktail manner) was used as a measure of activity for the individual cytochrome P450 (CYPs) in a po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent